Core Laboratories Financials - Benzinga

Core Laboratories Inc

CLBNYSE

Trade with Public

Trade with Public

$12.45

0.020.16%

At close: Aug 12, 5:00 PM EST

$12.45

N/A

After Hours: 4:00 PM EST

Dividend: The dividend Ex-Date was 2 days ago

Overview News Earnings Forecast Price TargetsFinancialsSentiment Ownership Dividends Compare Options Stock Report

Core Laboratories Financials

Core Laboratories (CLB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Core Laboratories Q2 Adj. EPS $0.11 Beats $0.09 Estimate, Sales $124.609M Miss $125.100M Estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. This is a 42.11 percent decrease over earnings of $0.19 per share from the

Benzinga Newsdesk

PRO
Core Laboratories Sees Q3 GAAP EPS $0.12-$0.20 vs $0.16 Est; Sees Sales $128.500M-$135.500M vs $131.330M Est

Core Laboratories (NYSE:CLB) is looking for Q3 GAAP EPS of $0.12-$0.20 vs $0.16 analyst estimate. sees sales of $128.500 million-$135.500 million vs $131.330 million analyst estimate.

Benzinga Newsdesk

PRO
Core Laboratories Sees Q2 GAAP EPS $0.06-$0.12 vs $0.09 Est; Sees Sales $123.000M-$131.000M vs $127.900M Est

Core Laboratories (NYSE:CLB) is looking for Q2 GAAP EPS of $0.06-$0.12 vs $0.09 analyst estimate. sees sales of $123.000 million-$131.000 million vs $127.900 million analyst estimate.

Benzinga Newsdesk

PRO
Core Laboratories Q1 Adj. EPS $0.06 Misses $0.11 Estimate, Sales $121.797M Miss $124.935M Estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.11 by 45.45 percent. This is a 57.14 percent decrease over earnings of $0.14 per share from

Benzinga Newsdesk

Earnings Scheduled For April 29, 2026

Benzinga Insights

PRO
Core Laboratories Sees Q1 Adj EPS $0.05-$0.07 vs $0.14 Est; Lowers Q1 Sales Guidance from $124.000M-$130.000M to $119.000M-$123.000M vs $128.290M Est

Core Laboratories (NYSE:CLB) is looking for Q1 Adj EPS of $0.05-$0.07 vs $0.14 analyst estimate. Lowers Q1 sales outlook from $124.000 million-$130.000 million to $119.000 million-$123.000 million vs $128.290 million

Benzinga Newsdesk